Latest Regulatory News

Recce Pharmaceuticals has cleared a critical regulatory hurdle in Indonesia with a successful inspection of its Phase 3 clinical trial site for diabetic foot infections, paving the way for potential approval in 2026 amid a large and growing market.

Australian Silica Quartz Group (ASQ) is set to acquire Australian Kaolin, adding a 47Mt inferred kaolin resource at White Swan and launching a $750,000 placement to fund development. The deal hinges on shareholder approval and an Independent Expert’s fairness opinion.

Diversified United Investment Limited’s merger with Australian United Investment Company Limited has cleared its final legal hurdle, with DUI shares ceasing trade and shareholders set to receive new AUI shares.

VHM Limited has secured A$5 million through a fully underwritten placement priced at A$0.26 per share, funding critical early engineering and procurement ahead of a mid-2026 final investment decision for its Goschen Rare Earth and Mineral Sands Project.

Red Sky Energy is raising approximately AUD 4.2 million through a fully underwritten non-renounceable rights issue priced at 0.1 cents per share. The capital will fund participation in Santos-operated wells and support ongoing operations.

Vintage Energy and Vault Energy have agreed to negotiate a gas sales deal for Cullen-1 gas, aiming to fuel modular data centres onsite if flow tests confirm commercial viability. Vintage plans to fund testing via farm-out once permit tenure is secured.

Riedel Resources has secured a controlling interest in two vast gold projects in Western Australia's Laverton district, transforming it into a multi-jurisdictional gold explorer alongside its Arizona asset. The acquisition comes with a $2.5 million placement to fund aggressive exploration starting mid-2026.

Riedel Resources has secured majority control of two large gold projects in Western Australia’s Laverton district, transforming into a multi-jurisdictional explorer with a strong cash position to fund upcoming drilling campaigns.

Jupiter Energy reported US$1.68 million in unaudited oil sales revenue for Q1 2026, with production steady across its Kazakhstan fields and a recent well workover set to boost output.

Starpharma has secured FDA alignment on the clinical development plan for its DEP® HER2 radiotherapy candidate, paving the way for a first-in-human phase 1 study in advanced HER2-positive cancers scheduled for H2 2026.

Bass Oil’s March production faced Cooper Basin setbacks from heavy rains and storage limits, but trucking resumed in April with strong prices. Indonesian output remained steady with a sharp 47% price rise. The company is progressing its Vanessa gas field acquisition and Kiwi development with government backing.

Saturn Metals has divested its West Wyalong Gold Project interests to Xpedra Resources, receiving cash and shares, as it concentrates on advancing its flagship Apollo Hill Gold Project in Western Australia.